Skip to main content
Home
About
Risks
News
Forums
Groups
Maps
Maps-new
Maps-old
Resources
Articles, Reports
Contacts
Links
Map Your Neighborhood
Resource Topics
Resource nodes
Systems
Dashboards
User login
Username
*
Password
*
Create new account
Request new password
lake
What is the weather on the sun
Search form
Search
Language
Anonymous's groups in this site
User is not a member of any group.
Your groups across all your sites
User is not a member of any group.
Recent Content
Florida grand jury investigating COVID-19 vaccines finds no evidence of criminal activity0
Winter respiratory illnesses return with a vengeance
U.S. outgoing Surgeon General offers ‘parting prescription’: stronger community
Biden Administration Bars Including Medical Debt In Credit Scores
Maps show where COVID, flu and RSV cases are rising in the US
Recent Comments
CDC warns of 'high' respiratory virus activity as cases increase
1 week 3 days ago
Climate researchers share theories behind apparent surge
3 weeks 3 days ago
Climate change, warmer weather, blamed for Dengue fever outbreak
4 weeks 1 day ago
More testing underway after another California raw milk recall
1 month 1 week ago
Who's online
There is currently 1 user online.
mike kraft
You are here
Home
EU, Pfizer/BioNTech agree to cut COVID vaccine purchases
Primary tabs
View
(active tab)
Workflow
Fri, 2023-05-26 11:29 —
mike kraft
EU, Pfizer/BioNTech announce amendment to COVID vaccine contract
The European Union and drugmakers Pfizer and BioNTech said on Friday they had reached a deal to amend a COVID-19 vaccine contract, cutting the number the EU must buy and pushing the delivery deadline to 2026.
Maggie Fick
Reuters
Country / Region Tags:
Europe
Global
United States
General Topic Tags:
COVID-19
Boosters
Treatments
Government
Public Health
Vaccinations
Problem, Solution, SitRep, or ?:
Situation Report
Groups this Group Post belongs to:
RAC Vaccines and Vaccination Group
Economics
- Private group -
Log in
or
register
to post comments
howdy folks
Page loaded in 0.543 seconds.
Recent Comments